<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05060965</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00208192</org_study_id>
    <nct_id>NCT05060965</nct_id>
  </id_info>
  <brief_title>Inpatient Smoking Cessation Pilot Program</brief_title>
  <official_title>Smoking Cessation Pilot Program on 9 South</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are implementing a stepwise approach to cessation with a public health&#xD;
      focus to improve health outcomes for the investigators' pediatric patients. The investigators&#xD;
      are focusing on addressing caregiver smoking as a modifiable risk factor during time of&#xD;
      child's hospitalization as a window of opportunity to provide counseling and education to&#xD;
      families on secondhand and third hand smoke exposure as well as information on NRT products&#xD;
      to heighten caregiver contemplation for quitting. One of the central goals of the&#xD;
      investigators' project is to increase immediate access to Nicotine Replacement Therapy (NRT)&#xD;
      resources for families during hospitalization which pediatric providers could potentially&#xD;
      dose and prescribe to caregivers who are screened positive for smoking. Long-term cessation&#xD;
      care is provided by referrals to both the MD Quitline and the John Hopkins Tobacco Treatment&#xD;
      Clinic. Both are provided to allow participants options that the participants would find&#xD;
      preferable from an insurance and provider perspective.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Self-reported attempts to quit smoking</measure>
    <time_frame>Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months</time_frame>
    <description>Change in caregiver self-reported tobacco cessation attempt in the past 14-days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Frequency of usage of outpatient tobacco cessation services</measure>
    <time_frame>Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months</time_frame>
    <description>Change in frequency of caregiver self-reported usage of outpatient tobacco cessation services (Maryland Quitline or Johns Hopkins Tobacco Treatment Clinic).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Usage of nicotine replacement therapy products</measure>
    <time_frame>Baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months</time_frame>
    <description>Change in caregiver self-reported usage of nicotine replacement therapy in the past 14-days.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tobacco Use Cessation</condition>
  <arm_group>
    <arm_group_label>Cessation intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care.&#xD;
Nicotine replacement therapy: Nicoderm patches, gum, lozenges&#xD;
Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg)&#xD;
Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg)&#xD;
High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg)&#xD;
Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as &quot;recipients of NRT products&quot;.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine lozenge</intervention_name>
    <description>Nicotine replacement therapy</description>
    <arm_group_label>Cessation intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine gum</intervention_name>
    <description>Nicotine replacement therapy</description>
    <arm_group_label>Cessation intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine patch</intervention_name>
    <description>Nicotine replacement therapy</description>
    <arm_group_label>Cessation intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Maryland Quitline</intervention_name>
    <description>Telephone-based tobacco cessation service</description>
    <arm_group_label>Cessation intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>John Hopkins Tobacco Treatment Clinic</intervention_name>
    <description>Clinic-based tobacco cessation service</description>
    <arm_group_label>Cessation intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Caregivers of patients on an inpatient unit at Johns Hopkins Children's Center who&#xD;
             self-identify as tobacco users and wish to initiate tobacco cessation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breast feeding maternal caregivers.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mandeep S. Jassal, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aysha Jawed</last_name>
    <phone>6677763777</phone>
    <email>ajawed1@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mandeep S. Jassal</last_name>
    <phone>4109552035</phone>
    <email>mjassal1@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mandeep S. Jassal, MD, MPH</last_name>
      <phone>4102833117</phone>
      <email>mjassal1@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Mandeep Jassal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aysha Jawed, LCSW-C, MSW, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 20, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>De-identified participant data will be shared with researchers or sponsor upon review of a written request. The request will require a detailed description of the usage of the data and will require approval by the principal investigator. A data use agreement will be set-up and a plan for data removal (including timeline) will be established.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

